Today, the U.S. Food and Drug Administration is warning patients and health care professionals of risks associated with the use of unapproved or unauthorized devices for diabetes management, including continuous glucose monitoring systems, insulin pumps and automated insulin dosing systems. In the safety communication issued today, the agency noted that the use of unapproved or unauthorized devices could result in inaccurate blood glucose (sugar) measurements or unsafe insulin dosing, which can lead to injury requiring medical intervention or even death.
News you can use: health & drug safety updates
May 17, 2019
May 10, 2019
On May 10, the Pain Management Best Practices Inter-Agency Task Force, voted on its final recommendations and published the Report on Pain Management Best Practices: Updates, Gaps, Inconsistencies, and Recommendations, which emphasize the importance of providing balanced, individualized, patient-centered pain management to ensure better clinical outcomes for pain that improve quality of life and functionality for patients. The group recommended a broad framework of approaches for treating acute and chronic pain.
April 30, 2019
FDA requires stronger warnings about rare but serious incidents related to certain prescription insomnia medicines
The U.S. Food and Drug Administration announced the agency is requiring a new boxed warning – the agency’s most prominent warning – on certain prescription insomnia drugs to better ensure patients and their health care professionals have the information they need when considering use of these medicines. The boxed warning follows several reports of rare, but serious injuries and deaths resulting from various complex sleep behaviors after taking these medicines.
April 25, 2019
FDA launches public education campaign to encourage safe removal of unused opioid pain medicines from homes
The U.S. Food and Drug Administration today announced the launch of a new education campaign, "Remove the Risk" to help Americans understand the important role they play in removing and properly disposing of unused prescription opioids from their homes. Visit www.fda.gov/DrugDisposal and www.FDA.gov/RemovetheRisk and download fact sheets, social media and more. BeMedWise resources include: Safe medicine storage & disposal and Safe Disposal: An Important Part of Addressing Opioid Abuse.
April 24, 2019
Safe Kids Worldwide, recently released the research report, Medicine Safety: A Key Part of Child-Proofing Your Home. This new report reviews trends in medicine poisoning for children and reveals findings from recent focus groups with parents of children under age 6, which provide insights into why, when most parents know they need to store medicine safely, children are still getting into medicine.
April 23, 2019
Take advantage to dispose of unused medications before they become household dangers. Dispose of them properly on National Prescription Take Back Day Saturday, April 27
Thousands of collection sites across America will participate in the 17th Annual National Prescription Drug Take Back Day on Saturday, April 27. This is a great opportunity for people around the country to make a difference in preventing the misuse and abuse of prescription opioids by safely disposing of their unused drugs. Too often, unused prescription drugs find their way into the wrong hands. That's dangerous and often tragic. To help find a disposal location in your state, please click on this tool from our partner Allied Against Opioid Abuse.
April 11, 2019
This webinar features discussion among opioid misuse health literacy experts about effective prevention strategies, approaches, and resources that can advance an understanding and a dialogue between older patients and their healthcare providers about opioid use. Presenters include prevention leaders from SAMHSA, the National Council on Aging, United Hospital Fund, and the Johns Hopkins Geriatric Workforce Enhancement program.
April 5, 2019
From 2010 to 2015, the rate of opioid-related hospital stays increased between 27 and 39 percent among patients age 65 and older, depending on the age group. Non-opioid-related hospital stays decreased 17 percent for patients age 65 and older and during the same period (HCUP Statistitical Frief #244 — updated September 2018).
March 27, 2019
Allied Against Opioid Abuse (AAOA) joined other leading national voices to raise awareness about the importance of prescription opioid safety. AAOA, along with the U.S. Centers for Disease Control and Prevention, Substance Abuse and Mental Health Services Administration, National Safety Council and others, contributed content to a special insert in USA Today as part of an opioid awareness issue developed by Mediaplanet. The BeMedWise Program at NeedyMeds is an AAOA National Partner.
March 20, 2019
Most people struggling with an opioid addiction do not have access to medications that could help them, including methadone, buprenorphine and extended-release naltrexone, according to a report from the National Academies of Sciences, Engineering, and Medicine. The study found only 6% of treatment facilities offered all three of the drugs in 2016, while only 5% of those addicted to opioids received medication for the addiction.